Unfortunately, one can observe that, from
approximately 20 traditional pharmaceutical companies investing in antibiotic
research in the 1980s, there are now only five with significant active
internal research programs. As a result, most novel antibiotic development is
now being conducted by small biotech companies.
Very interesting to observe that, increasing production of composites rich commercial and regional aircraft, development of new composite applications in different industries, an advancement in materials, increasing investment in research & development, increasing demand for light-weight materials, and rising quality and safety standards are major growth drivers of the testing market in the composites industry. According to Research and Markets, the global composites testing market was valued at US$ 1,189.7 million in 2016 and is projected to witness an excellent CAGR of 7.2% over the next five years to reach US$ 1,819.9 million in 2022.
Comments
Post a Comment